ALRN Insider Holders & Insider Ownership - Aileron Therapeutics Inc.

List of insiders holdings for Aileron Therapeutics Inc.:

Shares directly owned by the insider.
Shares indirectly owned by the insider.
Total shares owned by the insider (sum of shares directly and indirectly owned).
Total market value if available.
Shares are not adjusted for stock split.

"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>

Insider Holder Name	Report Date Time	Shares Owned Directly Indirectly	Total Shares Owned	Filing
UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO 10% Owner	2024-06-17 19:03:29	1,746,549 0	1,746,549	Form 4
APPLE TREE PARTNERS II LP 10% Owner	2018-07-10 16:26:25	1,380,241 0	1,380,241	Form 4
Novartis Bioventures Ltd NOVARTIS AG 10% Owner	2020-04-16 07:28:29	1,199,904 0	1,199,904	Form 13D
LV Management Group LLC Lilly Ventures Fund I LLC Torres S. Edward Hall Steven Edward Former 10% owner	2019-08-13 17:00:23	1,094,987 0	1,094,987	Form 13D
EXCEL MEDICAL FUND LP Gullans Steven R. Ph.D. Blume Frederick R. Enriquez Juan Excel Medical Ventures LLC 10% Owner	2017-07-13 17:01:03	1,016,100 0	1,016,100	Form 13D
Satter Muneer A See Remarks	2024-04-16 17:16:57	830,466 0	830,466	Form 13D
CVF LLC 10% Owner	2017-07-05 20:26:00	716,180 0	716,180	Form 4
ROCHE HOLDING LTD ROCHE FINANCE LTD 10% Owner	2017-07-05 20:27:55	702,363 0	702,363	Form 4
Apple Tree Partners II - Annex L.P. 10% Owner	2018-07-10 16:27:51	655,797 0	655,797	Form 4
KCK LTD. 10% Owner	2017-07-05 20:28:38	646,817 0	646,817	Form 4
AJU IB Investment Co. Ltd. 10% Owner	2017-07-07 19:13:33	0 517,558	517,558	Form 4
GLAXOSMITHKLINE PLC 10% Owner	2020-02-14 16:38:33	504,926 0	504,926	Form 13D
Sigma Emerging Markets Ltd. 10% Owner	2017-07-06 18:25:03	423,086 0	423,086	Form 4
Wanstall Rick See Remarks	2022-03-30 20:32:10	393,000 0	393,000	Form 4/A
Garner Charles Senior Vice President, Finance	2024-04-02 18:10:42	375,347 0	375,347	Form 3
Annis Allen SVP, Research	2022-03-30 20:31:54	313,000 0	313,000	Form 4/A
Gregory Kathryn SVP, Chief Business Officer	2020-02-04 16:30:40	185,000 0	185,000	Form 4
Yanchik Joseph A. III See Remarks	2017-07-27 18:35:57	157,449 0	157,449	Form 4
Vukovic Vojo Chief Medical Officer	2022-03-30 20:32:28	150,000 0	150,000	Form 4/A
Dougherty Donald SVP & Chief Financial Officer	2019-04-17 18:44:47	150,000 0	150,000	Form 4
Platt Jon B. 10% Owner	2017-07-05 20:28:27	90,318 0	90,318	Form 4
Bailey Jeffrey Allen Director	2022-06-17 17:10:49	54,500 0	54,500	Form 4
Sigal Nolan Howard Director	2022-06-17 17:12:32	54,500 0	54,500	Form 4
MCKEE WILLIAM Director	2022-06-17 17:18:27	54,500 0	54,500	Form 4
Morrison Jodie Pope Director	2022-06-17 17:22:19	54,500 0	54,500	Form 4
Nelson Kira See Remarks	2017-07-27 18:42:20	36,844 0	36,844	Form 4
MCARTHUR JOHN H Director	2019-06-21 16:07:55	25,000 0	25,000	Form 4
Gallagher Brian M. Jr. Director	2017-07-27 18:27:51	20,000 0	20,000	Form 4
LONGENECKER JOHN P PHD President and CEO	2018-08-14 19:38:24	10,000 0	10,000	Form 4
Shanafelt Armen Director	2018-06-25 18:25:49	10,000 0	10,000	Form 4
Winder Caleb Maxfield Director	2018-06-25 18:13:47	10,000 0	10,000	Form 4
WINDSOR JAMES BRIAN President and COO	2024-03-06 17:06:15	7,122 225	7,347	Form 4
Musso Alan A Director	2024-08-22 16:05:58	2,725 0	2,725	Form 4
Ambros Reinhard J. Director	2024-08-22 16:06:16	2,725 0	2,725	Form 4
Fairey William Director	2024-08-22 16:06:55	2,725 0	2,725	Form 4
VON RICKENBACH JOSEF H Director	2024-08-22 16:07:24	2,725 0	2,725	Form 4
Aivado Manuel Director	2024-08-22 16:09:02	2,725 0	2,725	Form 4
Kapnick Scott Director 10% Owner	2024-02-05 13:20:21	0 0	0	Form 13G
Drexler Susan L. See Remarks	2022-06-17 17:12:17	0 0	0	Form 3
Cunningham Timothy M. See Remarks	2024-05-16 17:19:29	0 0	0	Form 3

Insider Holders & Insider Ownership - Aileron Therapeutics Inc. (ALRN)